RO114835B1 - Metodă rapidă de diagnostic al cancerelor - Google Patents

Metodă rapidă de diagnostic al cancerelor

Info

Publication number
RO114835B1
RO114835B1 RO97-00502A RO9700502A RO114835B1 RO 114835 B1 RO114835 B1 RO 114835B1 RO 9700502 A RO9700502 A RO 9700502A RO 114835 B1 RO114835 B1 RO 114835B1
Authority
RO
Romania
Prior art keywords
cancer
diagnosing cancer
fast
fast diagnosing
cancer diagnosis
Prior art date
Application number
RO97-00502A
Other languages
English (en)
Inventor
Ioan Puşcaş
Iuliana Carmen Puşcaş
Marcela Colţău
Gabriela Domuţa
Original Assignee
Ioan Puşcaş
Iuliana Carmen Puşcaş
Marcela Colţău
Gabriela Domuţa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioan Puşcaş, Iuliana Carmen Puşcaş, Marcela Colţău, Gabriela Domuţa filed Critical Ioan Puşcaş
Priority to RO97-00502A priority Critical patent/RO114835B1/ro
Priority to CN98805210A priority patent/CN1256713A/zh
Priority to CA002284632A priority patent/CA2284632A1/en
Priority to EP98912475A priority patent/EP0972072B1/en
Priority to AU67298/98A priority patent/AU738843B2/en
Priority to JP54011798A priority patent/JP2001524815A/ja
Priority to EA199900775A priority patent/EA003185B1/ru
Priority to BR9808373-2A priority patent/BR9808373A/pt
Priority to AT98912475T priority patent/ATE209256T1/de
Priority to DE69803279T priority patent/DE69803279D1/de
Priority to US09/381,319 priority patent/US6326161B1/en
Priority to PCT/EP1998/001465 priority patent/WO1998041649A2/en
Priority to NZ337850A priority patent/NZ337850A/en
Publication of RO114835B1 publication Critical patent/RO114835B1/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Metoda conform invenţiei constă în aceea că diluţii diferite de ser sanguin se tratează, în raport volumetric de 1:1, cu soluţie apoasă de concentraţii 10M...10M anhidrază carbonică II purificată, la temperatura de 20...25°C şi pH=7,5, după care se determină activitatea anhidrazei carbonice II în mod cunoscut, iar valori ale activării de către ser a anhidrazei carbonice II mai mari de 100% indică prezenţa bolii canceroase.
RO97-00502A 1997-03-17 1997-03-17 Metodă rapidă de diagnostic al cancerelor RO114835B1 (ro)

Priority Applications (13)

Application Number Priority Date Filing Date Title
RO97-00502A RO114835B1 (ro) 1997-03-17 1997-03-17 Metodă rapidă de diagnostic al cancerelor
CN98805210A CN1256713A (zh) 1997-03-17 1998-03-13 癌症的快速诊断方法
CA002284632A CA2284632A1 (en) 1997-03-17 1998-03-13 Rapid method of cancer diagnosis
EP98912475A EP0972072B1 (en) 1997-03-17 1998-03-13 Rapid method of cancer diagnosis
AU67298/98A AU738843B2 (en) 1997-03-17 1998-03-13 Rapid method of cancer diagnosis
JP54011798A JP2001524815A (ja) 1997-03-17 1998-03-13 迅速なガン診断方法
EA199900775A EA003185B1 (ru) 1997-03-17 1998-03-13 Быстрый способ диагностики рака
BR9808373-2A BR9808373A (pt) 1997-03-17 1998-03-13 Processo rápido para o diagnóstico de câncer
AT98912475T ATE209256T1 (de) 1997-03-17 1998-03-13 Schnelle krebs-diagnose
DE69803279T DE69803279D1 (de) 1997-03-17 1998-03-13 Schnelle krebs-diagnose
US09/381,319 US6326161B1 (en) 1997-03-17 1998-03-13 Rapid motor for cancer diagnosis
PCT/EP1998/001465 WO1998041649A2 (en) 1997-03-17 1998-03-13 Rapid method of cancer diagnosis
NZ337850A NZ337850A (en) 1997-03-17 1998-03-13 Detecting the presence of a carcinogenic process in a subject in the asymptomatic phase of the disease using the tumour marker carbonic anhydrase II

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO97-00502A RO114835B1 (ro) 1997-03-17 1997-03-17 Metodă rapidă de diagnostic al cancerelor

Publications (1)

Publication Number Publication Date
RO114835B1 true RO114835B1 (ro) 1999-07-30

Family

ID=20104983

Family Applications (1)

Application Number Title Priority Date Filing Date
RO97-00502A RO114835B1 (ro) 1997-03-17 1997-03-17 Metodă rapidă de diagnostic al cancerelor

Country Status (13)

Country Link
US (1) US6326161B1 (ro)
EP (1) EP0972072B1 (ro)
JP (1) JP2001524815A (ro)
CN (1) CN1256713A (ro)
AT (1) ATE209256T1 (ro)
AU (1) AU738843B2 (ro)
BR (1) BR9808373A (ro)
CA (1) CA2284632A1 (ro)
DE (1) DE69803279D1 (ro)
EA (1) EA003185B1 (ro)
NZ (1) NZ337850A (ro)
RO (1) RO114835B1 (ro)
WO (1) WO1998041649A2 (ro)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100135980A1 (en) * 2000-10-16 2010-06-03 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
US7329495B2 (en) * 2004-06-09 2008-02-12 Board Of Regents, The University Of Texas System Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
PT2526422T (pt) * 2010-01-21 2016-08-23 The Res Found Of State Univ Of New York Método de diagnóstico da doença de sjögren
GB201009798D0 (en) * 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
US20120231479A1 (en) 2010-09-09 2012-09-13 Robert Puskas Combination methods of diagnosing cancer in a patient
US20150203892A1 (en) * 2012-09-05 2015-07-23 Wako Pure Chemical Industries, Ltd. Method for determining breast cancer
CN104630380B (zh) * 2015-03-06 2016-08-24 河北医科大学第四医院 碳酸酐酶iv在制备肺腺癌诊断制剂中的应用
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
CN105785004B (zh) * 2016-03-31 2017-11-10 中国医学科学院北京协和医院 细胞分裂周期相关蛋白2在胰腺癌诊断或预后中的用途
CN108287239B (zh) * 2017-12-08 2020-07-17 福建医科大学附属第一医院 血清ca2蛋白在制备肝癌诊断或预后评估试剂盒中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma

Also Published As

Publication number Publication date
JP2001524815A (ja) 2001-12-04
EA003185B1 (ru) 2003-02-27
WO1998041649A2 (en) 1998-09-24
EP0972072A2 (en) 2000-01-19
DE69803279D1 (de) 2002-02-21
CA2284632A1 (en) 1998-09-24
BR9808373A (pt) 2000-05-23
EP0972072B1 (en) 2001-11-21
EA199900775A1 (ru) 2000-06-26
NZ337850A (en) 2001-07-27
US6326161B1 (en) 2001-12-04
ATE209256T1 (de) 2001-12-15
CN1256713A (zh) 2000-06-14
WO1998041649A3 (en) 1998-12-23
AU6729898A (en) 1998-10-12
AU738843B2 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
EP0288082A3 (en) A tumor specific assay for ca125 ovarian cancer antigen
EP1630235A3 (en) Compounds for immunodiagnosis of prostate cancer and method for their use
EP2270214A3 (en) Method for diagnosing non-small cell lung cancers
RO114835B1 (ro) Metodă rapidă de diagnostic al cancerelor
SG46455A1 (en) Intraoperative and endoscopic tumor detection and therapy
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
ATE238555T1 (de) Krebsbehandlung
WO2004056874A3 (en) Neuropilin-1 inhibitors
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
WO2001021192A3 (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
ES2176523T3 (es) Procedimiento para la deteccion de la enfermedad de alzheimer.
CA2067797A1 (en) Production and use of human nm23 protein and antibodies therefor
WO2002063048A3 (en) Methods for predicting sensitivity of tumors to arginine deprivation
ATE132977T1 (de) Verfahren zum nachweis von krankheiten
CA2255540A1 (en) Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers